Fig. 1From: PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case reportChange in largest dimensions of neck mass on CT scans over treatment period. a Prior to pembrolizumab. 8.8 × 5.9 cm. b Best response to pembrolizumab. 6 × 4 cm. c Progression on pembrolizumab. 7.1 × 7.2 cm. d Post radiation 5.9 × 3.4 cmBack to article page